Market Closed -
Toronto S.E.
03:08:54 2024-04-30 pm EDT
|
5-day change
|
1st Jan Change
|
0.005
CAD
|
-.--%
|
|
-.--%
|
-60.00%
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
426.9
|
110.1
|
76.13
|
40.24
|
28.37
|
5.577
|
Enterprise Value (EV)
1 |
348.8
|
72.24
|
66.23
|
25.41
|
24.36
|
5.326
|
P/E ratio
|
-10.8
x
|
-1.72
x
|
-2.9
x
|
-1.64
x
|
-1.75
x
|
-0.35
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
22.4
x
|
6.74
x
|
3.03
x
|
1.76
x
|
1.29
x
|
0.26
x
|
EV / Revenue
|
18.3
x
|
4.42
x
|
2.64
x
|
1.11
x
|
1.1
x
|
0.25
x
|
EV / EBITDA
|
-11.5
x
|
-2.79
x
|
-2.65
x
|
-1.06
x
|
-1.75
x
|
-0.46
x
|
EV / FCF
|
-
|
-5,101,348
x
|
-2,997,772
x
|
-3,155,232
x
|
-2,326,193
x
|
-6,930,276
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
3.92
x
|
1.97
x
|
2.6
x
|
1.55
x
|
2.13
x
|
1.61
x
|
Nbr of stocks (in thousands)
|
307,157
|
323,762
|
323,954
|
402,369
|
436,446
|
557,696
|
Reference price
2 |
1.390
|
0.3400
|
0.2350
|
0.1000
|
0.0650
|
0.0100
|
Announcement Date
|
5/31/19
|
4/30/20
|
3/30/21
|
3/25/22
|
3/30/23
|
4/2/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
19.04
|
16.34
|
25.1
|
22.82
|
22.07
|
21.66
|
EBITDA
1 |
-30.45
|
-25.89
|
-24.99
|
-24.02
|
-13.93
|
-11.51
|
EBIT
1 |
-31.76
|
-27.63
|
-26.2
|
-25.33
|
-15.12
|
-12.56
|
Operating Margin
|
-166.82%
|
-169.08%
|
-104.36%
|
-110.99%
|
-68.52%
|
-57.97%
|
Earnings before Tax (EBT)
1 |
-33.63
|
-63.6
|
-26.18
|
-23.64
|
-18.92
|
-14.12
|
Net income
1 |
-33.28
|
-63.17
|
-26.25
|
-23.8
|
-15.44
|
-14.13
|
Net margin
|
-174.81%
|
-386.57%
|
-104.56%
|
-104.3%
|
-69.94%
|
-65.22%
|
EPS
2 |
-0.1284
|
-0.1973
|
-0.0810
|
-0.0610
|
-0.0371
|
-0.0290
|
Free Cash Flow
|
-
|
-14.16
|
-22.09
|
-8.054
|
-10.47
|
-0.7685
|
FCF margin
|
-
|
-86.67%
|
-88.01%
|
-35.3%
|
-47.45%
|
-3.55%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/31/19
|
4/30/20
|
3/30/21
|
3/25/22
|
3/30/23
|
4/2/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
78.2
|
37.8
|
9.9
|
14.8
|
4.01
|
0.25
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-14.2
|
-22.1
|
-8.05
|
-10.5
|
-0.77
|
ROE (net income / shareholders' equity)
|
-
|
-76.5%
|
-62.4%
|
-86.5%
|
-94.8%
|
-168%
|
ROA (Net income/ Total Assets)
|
-
|
-18.7%
|
-30.6%
|
-41%
|
-32.2%
|
-46.1%
|
Assets
1 |
-
|
337.8
|
85.72
|
58.03
|
47.88
|
30.66
|
Book Value Per Share
2 |
0.3500
|
0.1700
|
0.0900
|
0.0600
|
0.0300
|
0.0100
|
Cash Flow per Share
2 |
0.2500
|
0.1200
|
0.0300
|
0.0300
|
0.0100
|
0
|
Capex
1 |
1.15
|
0.53
|
3.44
|
0.37
|
0.69
|
0.33
|
Capex / Sales
|
6.05%
|
3.22%
|
13.69%
|
1.61%
|
3.14%
|
1.53%
|
Announcement Date
|
5/31/19
|
4/30/20
|
3/30/21
|
3/25/22
|
3/30/23
|
4/2/24
|
|
1st Jan change
|
Capi.
|
---|
| -60.00% | 2.16M | | +86.83% | 375M | | +51.55% | 313M | | +69.77% | 220M | | +89.13% | 171M | | +148.11% | 123M | | -14.29% | 144M | | +23.08% | 106M | | +150.00% | 75.33M | | -6.02% | 51.09M |
Medical Farming
|